Denagard® 200 Injection (UK)

Denagard 200 Injection is in the form of a clear, pale yellow, sterile, oily solution for intramuscular administration to pigs. Each ml provides tiamulin base, equivalent to 200 mg tiamulin hydrogen fumarate, formulated in sesame oil.

100 ml multidose glass vials.

The following organisms show sensitivity to tiamulin in vitro:
Brachyspira: Brachyspira hyodysenteriae, B. pilosicoli.
Mycoplasmas: Mycoplasma hyopneumoniae, M. hyorhinis, M.hyosynoviae, M. dispar, M. bovirhinis, M. bovis, Ureaplasma spp., M. gallisepticum, M. synoviae, M. meleagridis.
Gram-positive: Staphylococcus spp., Streptococcus spp., Corynebacterium pyogenes.
Gram-negative: Pasteurella spp., Klebsiella pneumoniae, Actinobacillus (Haemophilus) spp., Fusobacterium necrophorum, Bacteroides spp., Campylobacter coli, Lawsonia intracellularis.

For the treatment of swine dysentery caused by Brachyspia hyodysenteriae complicated by Fusobacterium spp. and Bacteroides spp.
 

For the treatment of enzootic pneumonia complex caused by M. hyopneumoniae and where the secondary bacteria are sensitive to tiamulin.
 

For the treatment of arthritis caused by Mycoplasma hyosynoviae to reduce lameness and restore growth performance.

Swine dysentery Treatment:
The dose is 1 ml/20 kg bodyweight (equivalent to 10 mg tiamulin hydrogen fumarate/kg bodyweight) administered intramuscularly as a single treatment to pigs showing clinical signs of the disease. Follow up treatment should be provided when necessary either with Denagard 12.5 % Solution in the drinking water or Denagard Premix in the feed.
 

Mycoplasmal Arthritis Treatment and Enzootic Pneumonia Complex of Pigs Treatment:
The dose is 1.5 ml/20 kg bodyweight (equivalent to 15 mg tiamulin hydrogen fumarate/kg bodyweight) daily, administered intramuscularly for a period of 3 consecutive days to pigs showing clinical signs of the disease.

Warnings:
Animals must not be slaughtered for human consumption during treatment. Pigs may be slaughtered for human consumption only after 10 days from the last treatment.
 

Contra-indications:
Animals should not receive products containing monensin, narasin or salinomycin, during or for at least seven days before or after treatment with Denagard 200 Injection. Severe growth depression or death may result.
 

Pharmaceutical Warnings:
 

• Store below 25°C.
• Protect from light and excessive heat.
• Do not refrigerate.
• This product does not contain an antimicrobial preservative.
• Following withdrawal of the first dose, use the product within 28 days.
• Discard unused material.
• Swab the rubber septum before removing each dose.
• Use a dry sterile needle and syringe.

 
 

Precautions:

• For intramuscular use in pigs only.
• On rare occasions, erythema or mild oedema of the skin may occur in pigs following the use of this product.
• As the product is formulated with sesame oil, it is important to ensure that the syringe used is dry. The admixture of oil and water may cause the plunger to stick.

For animal treatment only.
 

Keep out of reach of Children.
 

® Registered trademark of Novartis AG, Basel, Switzerland.
 

 

For additional related information click below: